α-Adrenergic regulation of androgen receptor concentration in the preoptic area of the rat

Robert J Handa, John A. Resko

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We examined the effect of the pharmacological disruption of the catecholaminergic system on the concentration of nuclear androgen receptor, as measured by the in vitro binding of methyltrienolone ([3H]R1881) to salt extracts of anterior pituitary (AP), preoptic are (POA) and medial basal hypothalamus (MBH). Treatment of gonadectomized male and female rats with the dopamine-ß-hydroxylase inhibitor, diethyldithiocarbamate (400 mg/kg b. wt.), 30 min before treatment with dihydrotestosterone (1 mg/animal) produced a decrease in the number of nuclear androgen receptor compared with saline-treated controls (P<0.05). This effect was specific for the POA and was not present 15 h after DHT treatment. There was no effect on cytosolic androgen receptor nor was there a drug effect on the apparent dissociation constant (Kd) of [3H]R1881 binding to hypothalamus-preoptic area cytosols. Treatment of intact males and castrated, testosterone-treated males with the a1- and a2-adrenergic antagonists, prazosin (5 mg/kg b. wt.) and yohimbine (2 mg/kg b. wt.), respectively, resulted in a significant decrease in the number of nuclear AR 2 h following drug treatment (P<0.05). There was no effect of the ß-adrenergic receptor antagonist propranolol (10 mg/kg b. wt.) when given to intact animals, nor was there an effect of idazoxan (5 mg/kg) when given to testosterone-treated animals. The effects of yohimbine and prazosin were restricted to the POA. None of the drugs competed with the binding of [3H]R1881 for the androgen receptor nor did they alter the Kd of cytosol or nuclear androgen receptor. These data provide evidence for an adrenergic interaction with the POA androgen receptor and suggest a role for catecholamines in modulating androgen sensitivity in the rat brain.

Original languageEnglish (US)
Pages (from-to)312-320
Number of pages9
JournalBrain Research
Volume483
Issue number2
DOIs
StatePublished - Apr 3 1989
Externally publishedYes

Fingerprint

Preoptic Area
Androgen Receptors
Metribolone
Adrenergic Agents
Cytoplasmic and Nuclear Receptors
Adrenergic Antagonists
Yohimbine
Prazosin
Cytosol
Testosterone
Pharmaceutical Preparations
Idazoxan
Middle Hypothalamus
Ditiocarb
Dihydrotestosterone
Mixed Function Oxygenases
Propranolol
Androgens
Hypothalamus
Catecholamines

Keywords

  • Androgen receptor
  • Hypothalamus
  • Idazoxin
  • Prazosin
  • Preoptic area
  • R1881
  • Yohimbine

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

α-Adrenergic regulation of androgen receptor concentration in the preoptic area of the rat. / Handa, Robert J; Resko, John A.

In: Brain Research, Vol. 483, No. 2, 03.04.1989, p. 312-320.

Research output: Contribution to journalArticle

@article{57989f605e064d60bc8bca29aa63ec23,
title = "α-Adrenergic regulation of androgen receptor concentration in the preoptic area of the rat",
abstract = "We examined the effect of the pharmacological disruption of the catecholaminergic system on the concentration of nuclear androgen receptor, as measured by the in vitro binding of methyltrienolone ([3H]R1881) to salt extracts of anterior pituitary (AP), preoptic are (POA) and medial basal hypothalamus (MBH). Treatment of gonadectomized male and female rats with the dopamine-{\ss}-hydroxylase inhibitor, diethyldithiocarbamate (400 mg/kg b. wt.), 30 min before treatment with dihydrotestosterone (1 mg/animal) produced a decrease in the number of nuclear androgen receptor compared with saline-treated controls (P<0.05). This effect was specific for the POA and was not present 15 h after DHT treatment. There was no effect on cytosolic androgen receptor nor was there a drug effect on the apparent dissociation constant (Kd) of [3H]R1881 binding to hypothalamus-preoptic area cytosols. Treatment of intact males and castrated, testosterone-treated males with the a1- and a2-adrenergic antagonists, prazosin (5 mg/kg b. wt.) and yohimbine (2 mg/kg b. wt.), respectively, resulted in a significant decrease in the number of nuclear AR 2 h following drug treatment (P<0.05). There was no effect of the {\ss}-adrenergic receptor antagonist propranolol (10 mg/kg b. wt.) when given to intact animals, nor was there an effect of idazoxan (5 mg/kg) when given to testosterone-treated animals. The effects of yohimbine and prazosin were restricted to the POA. None of the drugs competed with the binding of [3H]R1881 for the androgen receptor nor did they alter the Kd of cytosol or nuclear androgen receptor. These data provide evidence for an adrenergic interaction with the POA androgen receptor and suggest a role for catecholamines in modulating androgen sensitivity in the rat brain.",
keywords = "Androgen receptor, Hypothalamus, Idazoxin, Prazosin, Preoptic area, R1881, Yohimbine",
author = "Handa, {Robert J} and Resko, {John A.}",
year = "1989",
month = "4",
day = "3",
doi = "10.1016/0006-8993(89)90175-3",
language = "English (US)",
volume = "483",
pages = "312--320",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - α-Adrenergic regulation of androgen receptor concentration in the preoptic area of the rat

AU - Handa, Robert J

AU - Resko, John A.

PY - 1989/4/3

Y1 - 1989/4/3

N2 - We examined the effect of the pharmacological disruption of the catecholaminergic system on the concentration of nuclear androgen receptor, as measured by the in vitro binding of methyltrienolone ([3H]R1881) to salt extracts of anterior pituitary (AP), preoptic are (POA) and medial basal hypothalamus (MBH). Treatment of gonadectomized male and female rats with the dopamine-ß-hydroxylase inhibitor, diethyldithiocarbamate (400 mg/kg b. wt.), 30 min before treatment with dihydrotestosterone (1 mg/animal) produced a decrease in the number of nuclear androgen receptor compared with saline-treated controls (P<0.05). This effect was specific for the POA and was not present 15 h after DHT treatment. There was no effect on cytosolic androgen receptor nor was there a drug effect on the apparent dissociation constant (Kd) of [3H]R1881 binding to hypothalamus-preoptic area cytosols. Treatment of intact males and castrated, testosterone-treated males with the a1- and a2-adrenergic antagonists, prazosin (5 mg/kg b. wt.) and yohimbine (2 mg/kg b. wt.), respectively, resulted in a significant decrease in the number of nuclear AR 2 h following drug treatment (P<0.05). There was no effect of the ß-adrenergic receptor antagonist propranolol (10 mg/kg b. wt.) when given to intact animals, nor was there an effect of idazoxan (5 mg/kg) when given to testosterone-treated animals. The effects of yohimbine and prazosin were restricted to the POA. None of the drugs competed with the binding of [3H]R1881 for the androgen receptor nor did they alter the Kd of cytosol or nuclear androgen receptor. These data provide evidence for an adrenergic interaction with the POA androgen receptor and suggest a role for catecholamines in modulating androgen sensitivity in the rat brain.

AB - We examined the effect of the pharmacological disruption of the catecholaminergic system on the concentration of nuclear androgen receptor, as measured by the in vitro binding of methyltrienolone ([3H]R1881) to salt extracts of anterior pituitary (AP), preoptic are (POA) and medial basal hypothalamus (MBH). Treatment of gonadectomized male and female rats with the dopamine-ß-hydroxylase inhibitor, diethyldithiocarbamate (400 mg/kg b. wt.), 30 min before treatment with dihydrotestosterone (1 mg/animal) produced a decrease in the number of nuclear androgen receptor compared with saline-treated controls (P<0.05). This effect was specific for the POA and was not present 15 h after DHT treatment. There was no effect on cytosolic androgen receptor nor was there a drug effect on the apparent dissociation constant (Kd) of [3H]R1881 binding to hypothalamus-preoptic area cytosols. Treatment of intact males and castrated, testosterone-treated males with the a1- and a2-adrenergic antagonists, prazosin (5 mg/kg b. wt.) and yohimbine (2 mg/kg b. wt.), respectively, resulted in a significant decrease in the number of nuclear AR 2 h following drug treatment (P<0.05). There was no effect of the ß-adrenergic receptor antagonist propranolol (10 mg/kg b. wt.) when given to intact animals, nor was there an effect of idazoxan (5 mg/kg) when given to testosterone-treated animals. The effects of yohimbine and prazosin were restricted to the POA. None of the drugs competed with the binding of [3H]R1881 for the androgen receptor nor did they alter the Kd of cytosol or nuclear androgen receptor. These data provide evidence for an adrenergic interaction with the POA androgen receptor and suggest a role for catecholamines in modulating androgen sensitivity in the rat brain.

KW - Androgen receptor

KW - Hypothalamus

KW - Idazoxin

KW - Prazosin

KW - Preoptic area

KW - R1881

KW - Yohimbine

UR - http://www.scopus.com/inward/record.url?scp=0024563507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024563507&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(89)90175-3

DO - 10.1016/0006-8993(89)90175-3

M3 - Article

VL - 483

SP - 312

EP - 320

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -